BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36622034)

  • 1. Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids.
    Flashner S; Martin C; Matsuura N; Shimonosono M; Tomita Y; Morimoto M; Okolo O; Yu VX; Parikh AS; Klein-Szanto AJP; Yan K; Gabre JT; Lu C; Momen-Heravi F; Rustgi AK; Nakagawa H
    J Vis Exp; 2022 Dec; (190):. PubMed ID: 36622034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
    Ko KP; Huang Y; Zhang S; Zou G; Kim B; Zhang J; Jun S; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Park JI
    Gastroenterology; 2023 Sep; 165(3):613-628.e20. PubMed ID: 37257519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-Dimensional Organoids Reveal Therapy Resistance of Esophageal and Oropharyngeal Squamous Cell Carcinoma Cells.
    Kijima T; Nakagawa H; Shimonosono M; Chandramouleeswaran PM; Hara T; Sahu V; Kasagi Y; Kikuchi O; Tanaka K; Giroux V; Muir AB; Whelan KA; Ohashi S; Naganuma S; Klein-Szanto AJ; Shinden Y; Sasaki K; Omoto I; Kita Y; Muto M; Bass AJ; Diehl JA; Ginsberg GG; Doki Y; Mori M; Uchikado Y; Arigami T; Avadhani NG; Basu D; Rustgi AK; Natsugoe S
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):73-91. PubMed ID: 30510992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.
    Matrka MC; Cimperman KA; Haas SR; Guasch G; Ehrman LA; Waclaw RR; Komurov K; Lane A; Wikenheiser-Brokamp KA; Wells SI
    PLoS Genet; 2018 Mar; 14(3):e1007227. PubMed ID: 29538372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing mouse and human oral esophageal organoids to investigate the tumor immune response.
    Jiang Y; Zhao H; Kong S; Zhou D; Dong J; Cheng Y; Zhang S; Wang F; Kalra A; Yang N; Wei DD; Chen J; Zhang YW; Lin DC; Meltzer SJ; Jiang YY
    Dis Model Mech; 2024 Jan; 17(1):. PubMed ID: 38258518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-1β transgenic mouse model of inflammation driven esophageal and oral squamous cell carcinoma.
    Muthupalani S; Annamalai D; Feng Y; Ganesan SM; Ge Z; Whary MT; Nakagawa H; Rustgi AK; Wang TC; Fox JG
    Sci Rep; 2023 Aug; 13(1):12732. PubMed ID: 37543673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Derived Xenograft and Mice Models in Esophageal Squamous Cell Carcinoma.
    Lam AK; Tang JC
    Methods Mol Biol; 2020; 2129():137-147. PubMed ID: 32056175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD36 Expression Is Associated with Cancer Aggressiveness and Energy Source in Esophageal Squamous Cell Carcinoma.
    Yoshida T; Yokobori T; Saito H; Kuriyama K; Kumakura Y; Honjo H; Hara K; Sakai M; Miyazaki T; Obinata H; Erkhem-Ochir B; Gombodorj N; Sohda M; Saeki H; Kuwano H; Shirabe K
    Ann Surg Oncol; 2021 Feb; 28(2):1217-1227. PubMed ID: 32529269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma.
    Zhu H; Yip HC; Cheung MK; Chan HC; Ng C; Lau EHL; Yeung ZWC; Wong EWY; Leung L; Qu X; Wang D; Cai L; Chan PKS; Chan JYK; Chen Z
    Int J Cancer; 2023 May; 152(9):1903-1915. PubMed ID: 36752573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of heat shock protein 90 suppresses squamous carcinogenic progression in a mouse model of esophageal cancer.
    Wang S; Du Z; Luo J; Wang X; Li H; Liu Y; Zhang Y; Ma J; Xiao W; Wang Y; Zhong X
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1405-16. PubMed ID: 25563492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal Squamous Cancer from 4NQO-Induced Mice Model: CNV Alterations.
    Liu Z; Su R; Ahsan A; Liu C; Liao X; Tian D; Su M
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    He J; Zhou M; Chen X; Yue D; Yang L; Qin G; Zhang Z; Gao Q; Wang D; Zhang C; Huang L; Wang L; Zhang B; Yu J; Zhang Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):98. PubMed ID: 27329034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of esophageal squamous cell carcinoma (ESCC) in a murine 4-nitroquinoline-1-oxide and alcohol carcinogenesis model.
    Osei-Sarfo K; Urvalek AM; Tang XH; Scognamiglio T; Gudas LJ
    Oncotarget; 2015 Mar; 6(8):6040-52. PubMed ID: 25714027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice.
    Tang XH; Knudsen B; Bemis D; Tickoo S; Gudas LJ
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):301-13. PubMed ID: 14734483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of esophageal squamous cell carcinoma by cathepsin B activity in nude mice.
    Ma W; Ma L; Zhe H; Bao C; Wang N; Yang S; Wang K; Cao F; Cheng Y; Cheng Y
    PLoS One; 2014; 9(3):e92351. PubMed ID: 24618814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibitors prevent induction of cancer stem-like cells in esophageal squamous cell carcinoma by suppressing epithelial-mesenchymal transition.
    Sato F; Kubota Y; Natsuizaka M; Maehara O; Hatanaka Y; Marukawa K; Terashita K; Suda G; Ohnishi S; Shimizu Y; Komatsu Y; Ohashi S; Kagawa S; Kinugasa H; Whelan KA; Nakagawa H; Sakamoto N
    Cancer Biol Ther; 2015; 16(6):933-40. PubMed ID: 25897987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of DDX46 inhibits proliferation and induces apoptosis in esophageal squamous cell carcinoma cells.
    Li B; Li YM; He WT; Chen H; Zhu HW; Liu T; Zhang JH; Song TN; Zhou YL
    Oncol Rep; 2016 Jul; 36(1):223-30. PubMed ID: 27176873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer Organoids.
    Karakasheva TA; Kijima T; Shimonosono M; Maekawa H; Sahu V; Gabre JT; Cruz-Acuña R; Giroux V; Sangwan V; Whelan KA; Natsugoe S; Yoon AJ; Philipone E; Klein-Szanto AJ; Ginsberg GG; Falk GW; Abrams JA; Que J; Basu D; Ferri L; Diehl JA; Bass AJ; Wang TC; Rustgi AK; Nakagawa H
    Curr Protoc Stem Cell Biol; 2020 Jun; 53(1):e109. PubMed ID: 32294323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.